Yi Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi Wu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Xuebing Cao
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications - Yan Xu
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications An Chang
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publicationHaoxuan Ouyang
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publicationHeng Zhai
Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Peoples R China
1 shared publication- Heng Zhai
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Springer Nature in npj Parkinson's Disease
Multi-omics analysis of hypoxia-mitochondrial energy metabolism and programmed cell death profiling in Parkinson’s disease
Hypoxia and mitochondrial energy metabolism (MEM) impairment are pivotal features of Parkinson’s disease (PD), yet the regulators linking hypoxic stress to mitochondrial failure remain elusive. Here we integrated multiple transcriptomic datasets from the substantia nigra to characterize the hypoxia and MEM landscape. Utilizing a tripartite machine learning framework combined with LASSO-logistic regression, we developed a robust seven-gene diagnostic model that achieved high predictive accuracy (AUC: 0.887 training; 0.821 validation). Two-sample Mendelian randomization (MR) analysis further identified seven causal genes (TTC19, SERPINA1, MPC2, DLK1, DDIT4, AUH, and ASL) associated with PD risk. By integrating programmed cell death (PCD) profiling and scRNA-seq, we discovered that core regulators MPC2 and AUH were uniquely associated with novel PCD modes, showing negative correlations with alkaliptosis and positive correlations with cuproptosis. Single-cell analysis localized primary hypoxia-MEM impairment to dopaminergic neurons (DaNs), where MPC2 expression was significantly depleted. In silico virtual knockout of MPC2 disrupted dopamine metabolism and synaptic vesicle cycles, while STAT3 and MEF2A were identified as potential upstream transcription factors linking metabolic dysfunction to neuroinflammation. Together, our findings identify MPC2 as a genetically supported causal regulator linking hypoxia-MEM failure to novel PCD in DaNs, offering potential biomarkers and therapeutic targets for precision intervention in PD.
- 13 October 2026
- Published by Springer Nature in npj Parkinson's Disease
Open AccessMulti-omics analysis of hypoxia-mitochondrial energy metabolism and programmed cell death profiling in Parkinson’s disease
Hypoxia and mitochondrial energy metabolism (MEM) impairment are pivotal features of Parkinson’s disease (PD), yet the regulators linking hypoxic stress to mitochondrial failure remain elusive. Here we integrated multiple transcriptomic datasets from the substantia nigra to characterize the hypoxia and MEM landscape. Utilizing a tripartite machine learning framework combined with LASSO-logistic regression, we developed a robust seven-gene diagnostic model that achieved high predictive accuracy (AUC: 0.887 training; 0.821 validation). Two-sample Mendelian randomization (MR) analysis further identified seven causal genes (TTC19, SERPINA1, MPC2, DLK1, DDIT4, AUH, and ASL) associated with PD risk. By integrating programmed cell death (PCD) profiling and scRNA-seq, we discovered that core regulators MPC2 and AUH were uniquely associated with novel PCD modes, showing negative correlations with alkaliptosis and positive correlations with cuproptosis. Single-cell analysis localized primary hypoxia-MEM impairment to dopaminergic neurons (DaNs), where MPC2 expression was significantly depleted. In silico virtual knockout of MPC2 disrupted dopamine metabolism and synaptic vesicle cycles, while STAT3 and MEF2A were identified as potential upstream transcription factors linking metabolic dysfunction to neuroinflammation. Together, our findings identify MPC2 as a genetically supported causal regulator linking hypoxia-MEM failure to novel PCD in DaNs, offering potential biomarkers and therapeutic targets for precision intervention in PD.
- 1 August 2023
- Published by Elsevier in Behavioural Brain Research
- Vol. 454, 114609
Integrated PET/MRI With 11C-CFT and 18F-FDG for levodopa response difference in Parkinson’s disease
- 1 August 2023
- Published by Elsevier in Behavioural Brain Research
- Vol. 454, 114609
Integrated PET/MRI With 11C-CFT and 18F-FDG for levodopa response difference in Parkinson’s disease